|
|
| | 4-Imidazolidinecarboxamide, N-(3-chloro-2,4-difluorophenyl)-N-methyl-3-[6-methyl-4-(trifluoromethyl)-2-pyridinyl]-2-oxo-, (4S)- Basic information |
| | 4-Imidazolidinecarboxamide, N-(3-chloro-2,4-difluorophenyl)-N-methyl-3-[6-methyl-4-(trifluoromethyl)-2-pyridinyl]-2-oxo-, (4S)- Chemical Properties |
| density | 1.511±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 12.04±0.40(predicted) | | form | Solid | | color | White to off-white |
| | 4-Imidazolidinecarboxamide, N-(3-chloro-2,4-difluorophenyl)-N-methyl-3-[6-methyl-4-(trifluoromethyl)-2-pyridinyl]-2-oxo-, (4S)- Usage And Synthesis |
| Uses | PolQi1 is a Pol (polymerase theta) inhibitor. PolQi1 targets the polymerase domain of the enzyme[1]. | | References | [1] Wimberger S, et al. Simultaneous inhibition of DNA-PK and Pol improves integration efficiency and precision of genome editing. Nat Commun. 2023 Aug 14;14(1):4761. DOI:10.1038/s41467-023-40344-4 |
| | 4-Imidazolidinecarboxamide, N-(3-chloro-2,4-difluorophenyl)-N-methyl-3-[6-methyl-4-(trifluoromethyl)-2-pyridinyl]-2-oxo-, (4S)- Preparation Products And Raw materials |
|